Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Calixa Therapeutics Inc.
Headquarters:
San Diego, CA, United States
Website:
N/A
Year Founded:
2007
Status:
Acquired
BioCentury
|
Apr 28, 2014
Clinical News
Ceftolozane/tazobactam regulatory update
Read More
BioCentury
|
Dec 23, 2013
Clinical News
Ceftolozane/tazobactam: Phase III data
Read More
BioCentury
|
Dec 9, 2013
Clinical News
Ceftolozane/tazobactam: Phase III data
Read More
BioCentury
|
Jul 22, 2013
Clinical News
Ceftolozane/tazobactam: Phase III started
Read More
BioCentury
|
May 13, 2013
Clinical News
Ceftolozane/tazobactam regulatory update
Read More
BioCentury
|
Mar 18, 2013
Company News
Cubist, Astellas deal
Read More
BioCentury
|
Mar 18, 2013
Finance
Entering new Domains
Domain follows Russia play with Beijing Elite deal in China
Read More
BioCentury
|
Sep 10, 2012
Finance
Antibiotic replay
Calixa, Cerexa vets unveil antibiotic company Kalidex, backed by previous VCs
Read More
BioCentury
|
Sep 5, 2012
Company News
Kalidex debuts
Read More
BioCentury
|
Feb 6, 2012
Finance
Frazier's bumper crop
Frazier's record year of exits reflects M&A impact on biotech VCs
Read More
Items per page:
10
1 - 10 of 20